NO303223B1 - AnalogifremgangsmÕte for fremstilling av terapeutisk aktive bis-benzo- eller benzopyridocykloheptapiperiden-, piperidyliden- og piperazinforbindelser - Google Patents

AnalogifremgangsmÕte for fremstilling av terapeutisk aktive bis-benzo- eller benzopyridocykloheptapiperiden-, piperidyliden- og piperazinforbindelser

Info

Publication number
NO303223B1
NO303223B1 NO924955A NO924955A NO303223B1 NO 303223 B1 NO303223 B1 NO 303223B1 NO 924955 A NO924955 A NO 924955A NO 924955 A NO924955 A NO 924955A NO 303223 B1 NO303223 B1 NO 303223B1
Authority
NO
Norway
Prior art keywords
piperidylidene
benzo
benzopyridocycloheptapiperide
preparation
therapeutically active
Prior art date
Application number
NO924955A
Other languages
English (en)
Norwegian (no)
Other versions
NO924955L (no
NO924955D0 (no
Inventor
John J Piwinski
Michael J Green
Jesse K Wong
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO924955D0 publication Critical patent/NO924955D0/no
Publication of NO924955L publication Critical patent/NO924955L/no
Publication of NO303223B1 publication Critical patent/NO303223B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO924955A 1990-06-22 1992-12-21 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive bis-benzo- eller benzopyridocykloheptapiperiden-, piperidyliden- og piperazinforbindelser NO303223B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54228090A 1990-06-22 1990-06-22
PCT/US1991/004162 WO1992000293A1 (en) 1990-06-22 1991-06-21 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions

Publications (3)

Publication Number Publication Date
NO924955D0 NO924955D0 (no) 1992-12-21
NO924955L NO924955L (no) 1993-02-22
NO303223B1 true NO303223B1 (no) 1998-06-15

Family

ID=24163110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924955A NO303223B1 (no) 1990-06-22 1992-12-21 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive bis-benzo- eller benzopyridocykloheptapiperiden-, piperidyliden- og piperazinforbindelser

Country Status (26)

Country Link
US (1) US5422351A (cs)
EP (1) EP0535152B1 (cs)
JP (1) JPH0761998B2 (cs)
KR (1) KR960012368B1 (cs)
AT (1) ATE126226T1 (cs)
AU (1) AU646878B2 (cs)
CA (1) CA2085878C (cs)
CZ (1) CZ284610B6 (cs)
DE (2) DE69112061T2 (cs)
DK (1) DK0535152T3 (cs)
ES (1) ES2096657T3 (cs)
FI (1) FI925820A (cs)
GR (1) GR3017924T3 (cs)
HK (1) HK186496A (cs)
HU (1) HU220622B1 (cs)
IE (1) IE68935B1 (cs)
IL (1) IL98572A (cs)
NL (1) NL300378I2 (cs)
NO (1) NO303223B1 (cs)
NZ (1) NZ238629A (cs)
OA (1) OA10032A (cs)
PL (1) PL173224B1 (cs)
RU (1) RU2086549C1 (cs)
SK (1) SK374892A3 (cs)
WO (1) WO1992000293A1 (cs)
ZA (1) ZA914764B (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506249A (ja) * 1990-10-10 1993-09-16 シェリング・コーポレーション ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
AU2028892A (en) * 1991-05-23 1992-12-30 Schering Corporation Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
CA2114009A1 (en) * 1991-07-23 1993-02-04 Jesse K. Wong Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
JP2974529B2 (ja) * 1992-02-20 1999-11-10 北陸製薬株式会社 両性型三環系化合物
WO1993018744A1 (en) * 1992-03-23 1993-09-30 Janssen Pharmaceutica N.V. Agent for use as an anti-irritant
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5721236A (en) * 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US6075025A (en) * 1993-10-15 2000-06-13 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
ES2087818B1 (es) * 1993-11-24 1997-03-16 Uriach & Cia Sa J 8-cloro-11-(1-((5-metil-3-piridil)metil)-4-piperidiliden)-6,11-dihidro-5h-benzo-(5,6)cicloheptal(1,2-b)piridina, fumarato.
ES2087026B1 (es) * 1994-07-28 1997-03-16 Uriach & Cia Sa J Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina.
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US5684013A (en) * 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5891872A (en) * 1995-04-07 1999-04-06 Schering Corporation Tricyclic compounds
US5874442A (en) 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
US5965570A (en) * 1996-09-13 1999-10-12 Schering Corporation Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
CN1104428C (zh) * 1996-09-13 2003-04-02 先灵公司 用作法呢基-蛋白转移酶抑制剂的取代的苯并芳庚并吡啶
JP2001500507A (ja) * 1996-09-13 2001-01-16 シェーリング コーポレイション ファルネシルタンパク質トランスフェラーゼのインヒビターとして有用な新規三環式ピペリジニル化合物
AU740662B2 (en) * 1996-10-04 2001-11-08 Novo Nordisk A/S 1,4-disubstituted piperazines
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5958940A (en) * 1997-09-11 1999-09-28 Schering Corporation Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
CA2305801A1 (en) * 1997-10-10 1999-04-22 Schering Corporation Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo[5,6]cyclohepta [1,2-b]pyridin -11-ylidene)-1- piperidene carboxylate polymorph
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 hmg―co 억제제로서의 이의 용도
WO2006010202A1 (en) * 2004-07-28 2006-02-02 Ian Gray Pump control system
DK1896421T3 (da) 2005-06-23 2012-01-09 Merck Sharp & Dohme Benzocyclohetapyridiner som hæmmere af receptoren tyrosinkinase MET
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
CN103113348B (zh) * 2013-02-18 2015-03-25 扬子江药业集团江苏海慈生物药业有限公司 枸地氯雷他定的假多晶型及其制备方法
CN106588761B (zh) * 2016-11-22 2018-12-14 宜昌东阳光药业股份有限公司 一种氯雷他定中间体的合成方法
CN109608438A (zh) * 2018-12-05 2019-04-12 杭州澳医保灵药业有限公司 中间体化合物、其制备方法和应用、以及富马酸卢帕他定杂质j的制备方法
CN113004245B (zh) * 2019-12-20 2022-04-15 南京亿华药业有限公司 一种地氯雷他定制备方法
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途
CN113880808A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA780443A (en) * 1968-03-12 Sandoz Patents Limited 10 h-(1) benzothiopyrano (3,2-b) pyridine derivatives
US3267094A (en) * 1962-09-12 1966-08-16 Colgate Palmolive Co Morphanthridine derivatives
GB1046543A (en) * 1963-02-22 1966-10-26 Sandoz Ag Improvements in or relating to azathiaxanthene derivatives
NL132137C (cs) * 1963-04-24
US3419565A (en) * 1963-04-24 1968-12-31 Schering Corp Aza-dibenzocycloheptenes
US3381000A (en) * 1963-10-16 1968-04-30 Colgate Palmolive Co Certain 11-basic substituted-5, 6-dihydromorphanthridine compounds
BE638971A (cs) * 1963-10-21
US3325501A (en) * 1964-02-18 1967-06-13 Sandoz Ltd 9-[piperidylidene(4')]-1-aza-thiaxanthene-10-oxides and derivatives
US3336303A (en) * 1965-08-11 1967-08-15 Searle & Co Dibenzo-azacycloalkane-n-carboxylic acid hydrazides
US3409621A (en) * 1966-04-01 1968-11-05 Schering Corp Piperazino-aza-dibenzo-[a, d]-cycloheptenes
US3391143A (en) * 1966-05-16 1968-07-02 Smith Kline French Lab 9-piperidyl and 9-piperidylidene derivatives of acridan
US3504088A (en) * 1966-12-05 1970-03-31 Ciba Geigy Corp Pharmaceutical composition containing 11-amino-6-morphanthridones
US3803154A (en) * 1969-08-07 1974-04-09 Colgate Palmolive Co 11-cyclicaminoalkylidenemorphanthridines
US3803153A (en) * 1970-11-16 1974-04-09 Schering Corp Benzopyrano pyridines
US3717647A (en) * 1971-04-09 1973-02-20 Schering Corp Alpha-nicotinoyl phenylacetonitriles
US4072756A (en) * 1973-05-17 1978-02-07 Sandoz Ltd. Tricyclo piperidino ketones and soporific compositions thereof
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
US3966944A (en) * 1975-05-19 1976-06-29 Abbott Laboratories 10 (N-methyl-4-piperidylidene)-10H[1]-benzopyrano[3,2-b]-pyridine as an analgesic, anti-inflammatory and agent against type III hypersensitivity disease
US4021561A (en) * 1975-12-22 1977-05-03 Merck & Co., Inc. Trifluoromethylthio- and trifluoromethylsulfonyl-thioxanthen-9-ylidenepiperidines
DE2704934A1 (de) * 1976-02-17 1977-08-18 Sandoz Ag Organische verbindungen, ihre herstellung und verwendung
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
DE3170504D1 (en) * 1980-09-02 1985-06-20 Sandoz Ag Piperidylidene derivatives, their production and pharmaceutical compositions containing them
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4616023A (en) * 1984-04-05 1986-10-07 Merck & Co., Inc. Pharmaceutical compositions of 4-(dibenzo-[a,d]cycloalkenyl)piperazine compounds and methods
JPH0560831B1 (cs) * 1986-06-17 1993-09-03 Dainippon Pharmaceutical Co
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
JP2852659B2 (ja) * 1988-03-03 1999-02-03 富山化学工業株式会社 ピペラジン誘導体およびその塩
CA1341044C (en) * 1988-04-28 2000-07-04 Frank J. Villani Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same

Also Published As

Publication number Publication date
NO924955L (no) 1993-02-22
EP0535152A1 (en) 1993-04-07
FI925820A0 (fi) 1992-12-22
IE912124A1 (en) 1992-01-01
CA2085878C (en) 2000-06-13
FI925820A (fi) 1992-12-22
JPH0761998B2 (ja) 1995-07-05
EP0535152B1 (en) 1995-08-09
GR3017924T3 (en) 1996-01-31
IE68935B1 (en) 1996-07-24
NZ238629A (en) 1993-09-27
HU9204079D0 (en) 1993-03-29
PL173224B1 (pl) 1998-02-27
ES2096657T3 (es) 1997-03-16
SK280717B6 (sk) 2000-06-12
IL98572A0 (en) 1992-07-15
NO924955D0 (no) 1992-12-21
ZA914764B (en) 1992-03-25
WO1992000293A1 (en) 1992-01-09
DE69112061D1 (de) 1995-09-14
IL98572A (en) 1995-07-31
ATE126226T1 (de) 1995-08-15
HUT63161A (en) 1993-07-28
US5422351A (en) 1995-06-06
HU220622B1 (hu) 2002-03-28
PL297300A1 (cs) 1992-07-13
JPH05507092A (ja) 1993-10-14
CA2085878A1 (en) 1991-12-23
AU8225291A (en) 1992-01-23
OA10032A (en) 1996-10-14
CZ284610B6 (cs) 1999-01-13
RU2086549C1 (ru) 1997-08-10
NL300378I1 (nl) 2009-05-06
HK186496A (en) 1996-10-11
KR960012368B1 (ko) 1996-09-20
DK0535152T3 (da) 1995-09-25
NL300378I2 (nl) 2009-09-01
SK374892A3 (en) 2000-06-12
AU646878B2 (en) 1994-03-10
DE122008000047I2 (de) 2011-06-16
CZ374892A3 (en) 1993-10-13
DE69112061T2 (de) 1995-12-14

Similar Documents

Publication Publication Date Title
NO303223B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive bis-benzo- eller benzopyridocykloheptapiperiden-, piperidyliden- og piperazinforbindelser
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
NO853699L (no) Tetralinderivater, fremstilling og anvendelse derav.
NO305028B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive pyridin N-oxydderivater av diarylmethylpiperidiner eller piperaziner
DE69115280T2 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
FI925069A0 (fi) Nervskyddande indolon och naera anslutande derivat
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
NO974687D0 (no) Kondenserte <beta>-carboliner
FI863083A0 (fi) Foerfarande foer framstaellning av 2-asyl-3,4-dialkoxianiliner.

Legal Events

Date Code Title Description
MK1K Patent expired